THE HARPLE GROUP, LLC

Lobbying for GRAIL, INC. · Biotechnology Company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $30,000.00 income · posted Apr 14, 2026

Lobbying activity 1

Health Issues

Issues related to oncology and early multi-cancer detection, including diagnostics and screening.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.